Free Trial

3,697 Shares in Maximus, Inc. (NYSE:MMS) Acquired by Captrust Financial Advisors

Maximus logo with Business Services background

Captrust Financial Advisors purchased a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,697 shares of the health services provider's stock, valued at approximately $276,000.

Several other large investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its position in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares during the period. V Square Quantitative Management LLC boosted its stake in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd acquired a new stake in Maximus during the fourth quarter worth $54,000. IFP Advisors Inc increased its holdings in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares during the period. Finally, Farther Finance Advisors LLC raised its stake in shares of Maximus by 109.2% in the 4th quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after buying an additional 428 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Transactions at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This represents a 11.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Check Out Our Latest Stock Analysis on MMS

Maximus Price Performance

Shares of MMS traded up $2.21 during mid-day trading on Tuesday, reaching $74.61. The company had a trading volume of 395,575 shares, compared to its average volume of 561,827. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company's 50-day moving average is $69.59 and its 200-day moving average is $71.93. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a market capitalization of $4.20 billion, a P/E ratio of 16.05 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.57 EPS. On average, equities analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.61%. Maximus's dividend payout ratio is 23.86%.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines